Clinical Trial

'ADVANCE' (A Pilot Trial)

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study is being conducted to carefully study how chemotherapy is tolerated in group of patients age 70.
Protocol Amendment History 1 change
minor Completion pushed: 2026-06-30 -> 2026-12-30 2026-08-14
Trial Details
NCT Number NCT03858322
Lead Sponsor Dana-Farber Cancer Institute
Collaborators: Mayo Clinic
Conditions Breast Cancer
Enrollment 41 participants
Start Date 2019-03-21
Primary Completion 2020-11-10 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-13